 Malignant neoplasms exhibit elevated rate glycolysis normal cells. target Warburg effect, designed new series 2-deoxyglucose (2-DG) conjugated platinum (II) complexes glucose transporter 1 (GLUT1)-mediated anticancer drug delivery. potential GLUT1 transportability complexes investigated comparative molecular docking analysis utilizing latest GLUT1 protein crystal structure. key binding site 2-DG GLUT1's substrate identified molecular dynamics simulation, docking study demonstrated 2-DG conjugated platinum (II) complexes recognized binding site potential GLUT1 substrate. conjugates synthesized evaluated vitro cytotoxicity study seven human cancer cell lines. results study revealed 2-DG conjugated platinum (II) complexes GLUT1 transportable substrates exhibit improved cytotoxicities cancer cell lines express GLUT1 compared clinical drug, Oxaliplatin. correlation GLUT1 expression antitumor effects also confirmed. study provides fundamental information supporting potential 2-DG conjugated platinum (II) complexes lead compounds pharmaceutical R&D.